Pretargeting strategies for radio-immunoguided tumour localisation and therapy
- 1 February 1997
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (2), 186-192
- https://doi.org/10.1016/s0959-8049(96)00477-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Repeating the avidin “chase” markedly improved the biodistribution of radiolabelled biotinylated antibodies and promoted the excretion of additional background radioactivityEuropean Journal Of Cancer, 1995
- Tumor imaging with monoclonal antibodiesSeminars in Nuclear Medicine, 1995
- Immunotechnological trends in radioimmuno targetingNuclear Medicine Communications, 1995
- Development of a bispecific monoclonal antibody against a gallium-67 chelate and the human melanoma-associated antigen p97 for potential use in pretargeted immunoscintigraphyCancer Immunology, Immunotherapy, 1993
- Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibodyEuropean Journal of Cancer and Clinical Oncology, 1991
- Monoclonal antibody pretargetting techniques for tumour localizationNuclear Medicine Communications, 1991
- Intraperitoneal radio‐localization of tumors pre‐targeted by biotinylated monoclonal antibodiesInternational Journal of Cancer, 1990
- Tissue distribution of avidin and streptavidin injected to miceEuropean Journal of Biochemistry, 1990
- In vivo labelling of biotinylated monoclonal antibodies by radioactive avidin: A strategy to increase tumor radiolocalizationInternational Journal of Cancer, 1988
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975